A new long-acting reversible contraception (LARC) method offering protection from unplanned pregnancy for up to five years has been launched by Bayer. Kyleena releases a low daily dose of levonorgestrel in a five-year intrauterine system, using a small T-body and narrow insertion tube.

Lars Bruening, Bayer’s CEO and UK head of pharma, says: “Kyleena provides women with an additional, reliable and reversible contraceptive option.”


Infirst launches Flarin lipid ibuprofen capsules

Infirst has launched Flarin 200mg lipid ibuprofen soft capsules. It is initially available through LloydsPharmacy stores

Winter woes

As the seasons change, so will the type of advice and product recommendations that pharmacy teams offer to customers. To...